EGFR and urinary bladder carcinoma: Crosstalk of Met with the Src/EGFR signaling pathway has also been demonstrated in bladder carcinoma cells, in which serum-independent growth of the cells requires the activation of EGFR and Src, which leads to the phosphorylation of Met on Y1003 [89].